Vividion Therapeutics
CA - San DiegoBiotechnology
Focus: Vividion Therapeutics is an early-stage oncology biotech founded in 2023, leveraging proprietary screening technology to develop novel small-molecule therapeutics targeting advanced solid tumors. The company is publicly listed but remains in the discovery-to-Phase 1 stage with minimal commercial footprint.
Profile data last refreshed 23h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
2-5 this month
Cooling — net -5 jobs in 30d
1 added, 6 removed. Slower than typical.
Should You Work at Vividion Therapeutics?
AI assessmentVividion is a high-risk, early-stage platform play suited only for scientists seeking founding-team exposure and tolerance for uncertainty; limited institutional resources and scale make it unsuitable for those prioritizing stability or near-term advancement.
Why Work Here
- Ground-floor opportunity at a newly public company with proprietary screening platform differentiating its approach to oncology drug discovery
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
VVD-130850
Advanced Solid TumorsClinical Trials (1)
NCT06188208A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors
Phase 1Help build intelligence for Vividion Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.